The lab automation market is forecast to reach $5.20bn by 2022 from $4.06bn in 2017.
This is expected to be driven by miniaturisation, high demand for lab automation equipment in drug discovery and clinical diagnostics, higher reproducibility and accuracy, and large workforce demand and supply gap.
The genomics solutions segment is expected to grow at the highest rate during this period.
The rising need for high-throughput genomics in research labs and an increase in genetic testing in diagnostic labs, along with better accuracy and reproducibility, is contributing to the growth of lab automation solutions in genomics.
Picture credit | iStock